chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mom took patient to ER on 9/9/11 due to rash and again on 9/10/11. Saw PCP on 9/12/11.
Per mom, developed a wet raspy cough with green mucus, fever, and trouble breathing. Mother did not seek medical care and believes it was caused by flu vaccine.
Arm swelling, started to swell up early evening despite constantly moving it and massaging the shot site area. Fever came shortly thereafter, 99.9 then progressed higher throughout the night at 101.5. Body aches are immensely painful, hard to maneuver limbs. Also chills as my body has been constantly cold then hot. Extremely uncomfortable.
spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.; headache; nausea; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.), HEADACHE (headache), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (TARINA FE), TRETINOIN and CLINDAMYCIN for an unknown indication.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.), HEADACHE (headache), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ALOPECIA (spot on the back of her head a little bigger than golf ball where her hair is missing hair and all bald.), HEADACHE (headache), NAUSEA (nausea), PYREXIA (fever) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details include Ibuprofen
This case was reported by a healthcare professional and described the occurrence of tremor in a 51-year-old female subject who was vaccinated with influenza virus vaccine (FluLaval) for prophylaxis. The subject had received influenza virus vaccine in previous years with no subsequent adverse events.  On 09 November 2006 at 8:25 a.m., the subject received a dose of FluLaval.  On 09 November 2006 at 8:50 a.m., 25 minutes after vaccination with FluLaval, the subject experienced tremor, dizziness, and sweating.  The subject returned to the healthcare professional who had administered FluLaval.  The subject's blood pressure was elevated at 170/80 mm Hg and her blood sugar was decreased at 51.  The subject received juice, crackers and diphenhydramine hydrochloride (BENADRYL).  The subject then went to the emergency room and was released the same day. The healthcare professional considered the events were clinically significant (or requiring intervention).  The outcome of the events was not reported.  (OMIC)
Severe myalgia throughout most of body, difficult to walk quickly or get in/out of car seat. Moderate fatigue. Lasted approximately 2 days.
When I woke up in the morning my right eye was blurry and I could not focus at all. My right eye was swollen and red. At approximately 12:30 PM my right eye would focus but my vision was still blurry. later in the evening my right eye would focus. I did not seek medical help.
06/07 - fatigue / runny nose/ head ache/ sneezing  (continued) 06/08 -06/14 - cough, wheezing, body aches, fever, sore throat, fatigue 06/09 - started paxlovid 06/14 - coughing, sore throat, fatigue, laryngitis 06/16 - began antibiotic, coughing, fatigue 06/20 - began prednisone, coughing, fatigue 06/28 - no larygitis, coughing, fatigue 07/10 - coughing and fatigure waining
ACUTE ST ELEVATION MI, RIGHT CORONARY ARTERY ACUTE NON ST ELEVATION MI HYPOXEMIA 1/26/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Information has been received from a medical assistant concerning a male patient of unknown age. There was no information about the patient's medical history, concurrent conditions or concomitant therapies reported. On 30-JAN-2016, the patient was vaccinated with an improperly stored ZOSTAVAX lot number M036643 with expiration date of 19-NOV-2017 (strength, dose, dosage schedule, anatomical location and route of administration were not provided) for prophylaxis, and the administered dose was exposed to a temperature higher than 8°C but lower than 25°C for 20 hours (digital data logger) without any previous temperature excursion. No adverse effects were reported. There was no product quality complaint involved. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA000880:
Very bad rashes on body; Swelling face; Allergy; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy just to peaches and peanut butter. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 01Aug2021 the patient experienced allergy, very bad rashes on body and swelling face. The event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events and included treatment with unspecified antisthaminic. The clinical outcomes of the events allergy, very bad rashes on body and swelling face were unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Information has been received from a licensed practical nurse concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The nurse reported that on an unknown date, the patient received one dose of VARIVAX (either lot # M037642, expiration date September 2018; lot #N000681, expiration date 06-JAN-2019 [reported as 31-JAN-2019]; lot #M042858, expiration date October 2018; lot #N012486, expiration date April 2019; or lot #M045205, expiration date 11-NOV-2018) following temperature excursions of between -9°C and +8°C for 5 hours and 9-25°C (14.85°C) for 1.5 hours (route of administration not provided). No adverse effects were reported. Temperature/time frame: 14.85°C for 1.5 hours. Previous temperature excursion: Yes, -9°C to +8°C for 5 hours. Data logger involved: Yes. This is one of six cases from the same reporter concerning the same adverse event. It is unknown which lot number each patient received. 03-AUG-2017: Lot number N012486 has been verified to be a valid lot number for VARIVAX. Additional information has been requested. Sender's Comments: US-009507513-1708USA000471: US-009507513-1708USA000472: US-009507513-1708USA000473: US-009507513-1708USA000474: US-009507513-1708USA000475.
Pt reports that her menses has been irregular since getting the covid vaccine. She said she also is in the process of trying to conceive and and has not been able to detect ovulation at all since getting the vaccines.  Has failed two rounds of IUI to try to get pregnant  since getting the vaccines. She has been started bcp this last month to try and regulate her cycle.
Pt felt light headed and experienced slight vision loss within minutes after receiving the second dose of the Moderna vaccine. Pt assessed by EMT and recovered without intervention.
The blood work showed a high ANA (thyroid); After I go my second dose on 14Feb2021 about 1 month later, I started to get intermittent itching on skin,; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200449767 (Pfizer).  A 62 year-old male patient received bnt162b2 (BNT162B2), administration date 14Feb2021 (Batch/Lot number: unknown) at the age of 61 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose number: 1, Manufacture: Unknown), for Covid-19 immunization. The following information was reported: PRURITUS (non-serious) with onset Mar2021, outcome "unknown", described as "After I go my second dose on 14Feb2021 about 1 month later, I started to get intermittent itching on skin,"; ANTINUCLEAR ANTIBODY INCREASED (non-serious), outcome "unknown", described as "The blood work showed a high ANA (thyroid)". The events "after i go my second dose on 14feb2021 about 1 month later, i started to get intermittent itching on skin," and "the blood work showed a high ana (thyroid)" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pruritus.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200449766 similar report from same reporter
Tingling sensation across my back and down arms. But then became much more intense like pin pricks.; Numb hands. The sensation became really intense and spread into hips and thighs.; Felt similar to restless leg syndrome but then became much more intense like pin pricks; Upset stomach (frequent BMs all morning); Upset stomach (frequent BMs all morning); Headache in the afternoon; Very uncomfortable feeling of restlessness; Somewhat achy as well; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 25Feb2021 at 18:15 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included a similar reaction to whooping cough vaccine as the COVID-19 vaccine. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received pertussis vaccine (MANUFACTURER UNKNOWN) and experienced tingling, numbness, restless leg syndrome, upset stomach (frequent Bowel Movements (BMs)), restlessness, headache and ache (also reported in medical history). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 05Feb2021 at 18:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation.  On 26Feb2021 at 04:00, the patient experienced a tingling sensation across her back and down her arms and numb hands. The sensation became really intense and spread into her hips and thighs. It felt similar to restless leg syndrome but then it became much more intense like pin pricks and upset stomach (frequent Bowel Movements (BMs) all morning); then a headache in the afternoon. The tingling sensation had been persistent all day. The patient had a very uncomfortable feeling of restlessness and felt somewhat achy as well. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling, numbness, restless leg syndrome, upset stomach (frequent BMs), headache, restlessness and achy were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient states evening after injection left arm became black and blue from elbow to shoulder. States he is on Coumadin, levels have been okay
Making decision, mental unclarity; Can not think as clearly as before; fells a lot of pressure in her toes,; lightheadedness; numbness in her toes like a neuropathy, numbness in the ball of the foot and is more in the toes; Throw up  a week after  getting vaccinated; Had soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Making decision, mental unclarity), THINKING ABNORMAL (Can not think as clearly as before), LIMB DISCOMFORT (fells a lot of pressure in her toes,), DIZZINESS (lightheadedness) and HYPOAESTHESIA (numbness in her toes like a neuropathy, numbness in the ball of the foot and is more in the toes) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033H21A, 030B21A and 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy. Concomitant products included AMLODIPINE, SIMVASTATIN, LUTEIN [XANTOFYL], CALCIUM, MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], TOCOPHEROL (VITAMIN E [TOCOPHEROL]) and CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) for an unknown indication.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced CONFUSIONAL STATE (Making decision, mental unclarity), THINKING ABNORMAL (Can not think as clearly as before), LIMB DISCOMFORT (fells a lot of pressure in her toes,), DIZZINESS (lightheadedness), HYPOAESTHESIA (numbness in her toes like a neuropathy, numbness in the ball of the foot and is more in the toes), VOMITING (Throw up  a week after  getting vaccinated) and PAIN IN EXTREMITY (Had soreness in the arm). At the time of the report, CONFUSIONAL STATE (Making decision, mental unclarity), THINKING ABNORMAL (Can not think as clearly as before), LIMB DISCOMFORT (fells a lot of pressure in her toes,), DIZZINESS (lightheadedness), HYPOAESTHESIA (numbness in her toes like a neuropathy, numbness in the ball of the foot and is more in the toes), VOMITING (Throw up  a week after  getting vaccinated) and PAIN IN EXTREMITY (Had soreness in the arm) had not resolved.            Other concomitant medications included besylate 5mg.  The patient stated she did not know the date of  side effect happened.   No treatment medication were provided.
slept all day; feels tired; Fast heart beat; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (slept all day), FATIGUE (feels tired) and HEART RATE INCREASED (Fast heart beat) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (slept all day), FATIGUE (feels tired) and HEART RATE INCREASED (Fast heart beat). At the time of the report, SOMNOLENCE (slept all day), FATIGUE (feels tired) and HEART RATE INCREASED (Fast heart beat) outcome was unknown.            No concomitant medication information were provided. Patient received 2nd booster dose. No treatment information were provided.   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2022: Live Non Significant follow up appended.
Within 2 hours of vaccine administration, developed several hives around left arm and armpit no local reaction at injection site. No other symptoms. Rash went away after approx 2 hrs post x 1 dose (p.o.) of BENADRYL Pt w/ Hx of strawberry (past) and cat allergy.
Patient came in for her second dose on 5/16/21. I asked her if she had experienced any side effects with her first dose of moderna and she said that the following day she had left sided paralysis/pressure from the left side of the face down to the neck , arms and legs. Paralysis lasted for 30 minutes and she has not experienced any other form of paralysis since then. she does report being much more tired than usual ever since she had her first dose.
patient reported around 05/10/2022 being in the hospital for a few days. she received the covid vaccine (pfizer) due to the requirement of her employment. after receiving the vaccine, she experienced fluid retention, fever, and shortness of breath and had to use her oxygen. she believes that the vaccine is the cause of the symptoms. her doctor stated that the pulmonary hypertension medications had stopped working for 7-8 days and was not related to the vaccine. she feels a lot better, and things are getting back to normal. exact date of admission, length of stay and discharge are unknown. no other information is known. product lot number and expiration date were systematically retrieved from the dispensing system.
This spontaneous report as received from a health professional refers to a 18 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 04-NOV-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
According to vaccinee, MD said that yeast infection is due to Engerix-B; Vaccinee indicates first vax 21AUG90 lt deltoid & "in about" 2 days experienced a vaginal yeast infection;
On 9/1/09 Tues PM I received a 3rd Hep B injection in my Rt arm. It was sore and got increasing more inflamed as the week went on. Friday 9/4/09 after work I was in severe pain so I called the clinic told them of the situation and he told me to come right down. I was examined and given an anti inflammatory and an ice pac. He told me to come back Tues. I was unable to move (Labor day weekend) that weekend due to the pain. I had a fever and my entire rotator cuff was inflamed. It seemed I was on the mend (slightly) by Tues, when I went to the clinic and he seemed pleased  that my ROM was slightly better. Since that day I have had pain in my shoulder, trouble sleeping on either side unless it is propped or positioned and the pain and inflammation radiate to my fingers. They get swollen with use and with overuse cannot flex my index finger and my middle finger without pain and complete stiffness. Since then I have been taking mega doses of ALEVE and the chronic pain is starting to take a toll on me.
A spontaneous report was received from a consumer concerning a 65-years-old-female patient who experienced her right arm is red, itchy, site of injection was way lower than where it should be given, arm is red, and redness spread down injection site and passed her elbow. The patient's medical history was not provided. Concomitant product use was not provided. The patient received their first of two planned doses (Lot # 029L20A) intramuscularly in the right arm on 18 Jan 2021 for prophylaxis of COVID-19 infection. On 18 Jan 2021, the patient received vaccination with no problems on the day of injection. On 19 Jan 2021, patient's right arm was red and itchy. On 25 Jan 2021 (7 days later), patient got redness on arm, severe itching with the redness spreading down injection site and passed the elbow. The patient saw the physician and was given antibiotics. The patient went to the emergency room and was told it was a delayed reaction with vaccine. Patient was given Benadryl and five days later all these reactions cleared - redness was gone, little bit itchy, and everything was essentially resolved. The patient stopped taking Benadryl probably from Sunday. The patient was concerned on whether to receive the second shot scheduled on 15 Feb 2021. The patient was informed by physician that site of injection was way lower than where it should be given. Patient inquired about injection site and delayed reaction. Treatment for the events included antibiotics and Benadryl. Action taken was unknown. The events her right arm is red, itchy, site of injection was way lower than where it should be given, arm is red, and redness spread down injection site and passed her elbow were considered recovered / resolved.; Reporter's Comments: This case concerns a 65-year-old female patient who received their first of two planned doses (Lot 029L20A), reporting Product administered at inappropriate site and associated non-serious adverse events of Vaccination site pruritus, Vaccination site erythema, and Vaccination site joint erythema. Based on the current available information and temporal association between the use of the product and the onset date of the events, a causal relationship cannot be excluded.
w/in 24hr of vax pt exp a severe h/a & then devel a small stroke;hosp is presumed although not documented;no further info was available @ the date of this report;
hpi: arthritis, atrial fibrillation, hypertension, mrsa, sob, bph, ckd stage iii, colon cancer stage 3, contusion of left hand, depression, diabetes, facial contusion, facial laceration, fall, gerd, gout, head injuru without loc, hyperlipidemia, hypothyroidism, migraine, musculoskeletal neck pain, prostate enlargement, skin cancer, sleep apnea.  cause of death listed as respiratory failure due to COVID-19  HOSP COURSE: COVID-19 pneumonia symptoms started on 11/15 with presentation to the hospiatl on 11/19. Acure hypoxemia respiratory failure. acute metabolic encephalopathy secondary to multiple comorbidities; worsening acute on chronic kidney disease stage iii with creatinine going up to 2.57, bradycardia on precedex drip. leukopenia at presentation. outpt with leukemoide type  superimposed bacterial pneumonia with elevated procalitonin
Information has been received from a medical assistant referring to an unspecified number of patients (reported as only a few) of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies and concomitant medication were not reported. On unknown dates, the patients were vaccinated with unspecified doses of improperly stored GARDASIL 9 (lot # L016429 with expiration date 09-AUG-2017, dose and route were not reported). Since May 2016, the vaccine were improperly stored under 46.6. Fahrenheit (F) for cumulative time 838 hours. Data logger was involved. No adverse effects were reported. Additional information has been requested.